Controlled Sequential Oxygenation of Polyunsaturated Fatty Acids with a Recombinant Unspecific Peroxygenase from Aspergillus niger

The metabolism of polyunsaturated fatty acids (PUFAs) is a broad research field, and the products identified so far offer potential medical and industrial applications. Epoxy fatty acids (EpFAs) act as lipid mediators that modulate renal function, angiogenesis, vascular dilatation and inflammation; moreover, they regulate monocyte aggregation and are involved in cardiovascular and metabolic diseases. On the other hand, EpFAs are precursors of environmentally friendly products for the plastics industry, in which the grade of epoxidation of the compounds gives the polymeric material different advantageous characteristics. The controlled chemical synthesis of poly epoxidized PUFAs is challenging as the reactions are non-selective. In contrast, the biosynthetic route based on cytochrome P450 monooxygenases and lipoxygenases is highly selective but ineffective due to the instability of the enzymes in cell-free systems. Fungal unspecific peroxygenases (UPOs, EC 1.11.2.1) with P450-like activity offer a suitable alternative for the selective synthesis of EpFAs from PUFAs. Here we demonstrate that a recombinant unspecific peroxygenase from Aspergillus niger (rAniUPO) is able to sequentially epoxidize eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) to 14,15-17,18 diepoxyeicosatrienoic acid (14,15-17,18 diEpETrE) and 16,17-19,20-diepoxydocosatetraenoic acid (16,17-19,20 diEpDTE), respectively, while arachidonic acid is transformed into 13-hydroxy-14,15-epoxyeicosatrienoic acid (14,15-hepoxilin B3). Optimal production for these oxygenated derivatives (up to 15 mg) was achieved using 2 mM hydrogen peroxide as the co-substrate. The obtained molecules were identified using high-resolution mass spectrometry and their structure was verified by NMR. Our results demonstrate the suitability of UPOs for the synthesis of EpFAs that can be used in medical research and industrial applications.